Abstract
This review aims to highlight the recent findings of long non-coding RNAs (lncRNAs) in liver disease. In particular, we focus on the functions of lncRNAs in hepatocellular carcinoma (HCC) and non-alcoholic steatohepatitis (NASH). We summarize the current research trend in lncRNAs and their potential as biomarkers and therapeutic targets for the treatment of HCC and NASH.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 34 |
Tidsskrift | Non-coding RNA |
Vol/bind | 6 |
Udgave nummer | 3 |
Sider (fra-til) | 1-16 |
Antal sider | 16 |
ISSN | 2311-553X |
DOI | |
Status | Udgivet - 29 aug. 2020 |